Drug Profile
Research programme: INDRA compounds - Active Biotech
Alternative Names: INDRA compounds research programme - Active BiotechLatest Information Update: 17 May 2004
Price :
$50
*
At a glance
- Originator Active Biotech
- Class
- Mechanism of Action NF-kappa B inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Inflammatory bowel diseases
Most Recent Events
- 01 May 2004 Discontinued - Preclinical for Inflammatory bowel disease in Sweden (unspecified route)
- 21 Jun 2002 Preclinical trials in Inflammatory bowel disease in Sweden (unspecified route)